Literature DB >> 8639483

From good substrates to good inhibitors: design of inhibitors for serine and thiol proteases.

R Baggio1, Y Q Shi, Y Q Wu.   

Abstract

Serine and thiol proteases react with peptide substrates to form an acyl-enzyme. We have synthesized inhibitors which are pseudo-substrates and react with the proteases to generate acyl-enzymes which hydrolize slowly. This is achieved by incorporating an electron-donating group near the carbonyl group of inhibitors I [Ac-Phe--C(O)NH--NH--C(O)X] and II [benzyl-O-C(O)-psiAla-Leu-ArgOMe]. The acyl-enzymes derived from the reaction of I with papain and II with chymotrypsin hydrolyze with t1/2 of 12 and 1 h, respectively. The increased electron density on the carbonyl group of the inhibitor also reduces the rate of acyl-enzyme formation. Components were incorporated into the inhibitor which interact with the leaving group binding site (S' subsite) and which accelerate the rate of reaction of inhibitor with enzyme. For inhibitor I, X = NH(CH3), k(on) < 0.13 M(-1) s(-1) for the reaction papain, but if X = psiLeu(CH3)2,k(on) =10(5) M(-1) s(-1). Similar results were obtained with II and chymotrypsin. Concomitant with acyl-enzyme formation, X is released and a slowly hydrolyzing acyl-enzyme remains.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8639483     DOI: 10.1021/bi952879e

Source DB:  PubMed          Journal:  Biochemistry        ISSN: 0006-2960            Impact factor:   3.162


  7 in total

1.  Kinetic characterization and molecular docking of a novel, potent, and selective slow-binding inhibitor of human cathepsin L.

Authors:  Parag P Shah; Michael C Myers; Mary Pat Beavers; Jeremy E Purvis; Huiyan Jing; Heather J Grieser; Elizabeth R Sharlow; Andrew D Napper; Donna M Huryn; Barry S Cooperman; Amos B Smith; Scott L Diamond
Journal:  Mol Pharmacol       Date:  2008-04-10       Impact factor: 4.436

2.  Design, synthesis, and evaluation of inhibitors of cathepsin L: Exploiting a unique thiocarbazate chemotype.

Authors:  Michael C Myers; Parag P Shah; Mary Pat Beavers; Andrew D Napper; Scott L Diamond; Amos B Smith; Donna M Huryn
Journal:  Bioorg Med Chem Lett       Date:  2008-05-01       Impact factor: 2.823

3.  Design of potent and selective human cathepsin K inhibitors that span the active site.

Authors:  S K Thompson; S M Halbert; M J Bossard; T A Tomaszek; M A Levy; B Zhao; W W Smith; S S Abdel-Meguid; C A Janson; K J D'Alessio; M S McQueney; B Y Amegadzie; C R Hanning; R L DesJarlais; J Briand; S K Sarkar; M J Huddleston; C F Ijames; S A Carr; K T Garnes; A Shu; J R Heys; J Bradbeer; D Zembryki; L Lee-Rykaczewski; I E James; M W Lark; F H Drake; M Gowen; J G Gleason; D F Veber
Journal:  Proc Natl Acad Sci U S A       Date:  1997-12-23       Impact factor: 11.205

4.  Diarylcarbonates are a new class of deubiquitinating enzyme inhibitor.

Authors:  Marcus J C Long; Ann P Lawson; Rick Baggio; Yu Qian; Lior Rozhansky; Domenico Fasci; Farid El Oualid; Eranthie Weerapana; Lizbeth Hedstrom
Journal:  Bioorg Med Chem Lett       Date:  2018-11-28       Impact factor: 2.823

5.  Using substrate specificity of antiplasmin-cleaving enzyme for fibroblast activation protein inhibitor design.

Authors:  Kyung N Lee; Kenneth W Jackson; Simon Terzyan; Victoria J Christiansen; Patrick A McKee
Journal:  Biochemistry       Date:  2009-06-16       Impact factor: 3.162

6.  Identification and synthesis of a unique thiocarbazate cathepsin L inhibitor.

Authors:  Michael C Myers; Parag P Shah; Scott L Diamond; Donna M Huryn; Amos B Smith
Journal:  Bioorg Med Chem Lett       Date:  2007-11-01       Impact factor: 2.823

7.  Synthesis of acylhydrazino-peptomers, a new class of peptidomimetics, by consecutive Ugi and hydrazino-Ugi reactions.

Authors:  Angélica de Fátima S Barreto; Veronica Alves Dos Santos; Carlos Kleber Z Andrade
Journal:  Beilstein J Org Chem       Date:  2016-12-27       Impact factor: 2.883

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.